Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
The data driven fertility company helps increase the success rate of fertility treatments
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The HD-550 endoscopy system has been available outside of the USA since 2019
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Subscribe To Our Newsletter & Stay Updated
